CA-TALKDESK,-INC.
27.4.2021 17:44:08 CEST | Business Wire | Press release
Talkdesk®, Inc. , the global customer experience leader for customer-obsessed companies, today announced the launch of Talkdesk Digital Lending, a borrower solution designed for lenders to streamline and accelerate the lending lifecycle for personal, mortgage and commercial loans. Talkdesk Digital Lending enables lenders to service the recent surge in loan volumes, while also meeting compliance and regulatory requirements.
The availability of Talkdesk Digital Lending comes at a time when lenders are facing a fractured borrower experience. According to the Talkdesk CX Revolution in Financial Services and Insurance Report, customer experience (CX) professionals agree that delivering a positive borrowing experience across legacy processes is a challenge. Indeed, seven out of 10 cite challenges in loan servicing, loan origination, and in account opening and servicing.
Talkdesk Digital Lending addresses these challenges by providing a secure end-to-end contact center solution designed to improve borrower experiences, enabling lenders of all sizes to streamline the entire process — from loan origination through to servicing. Talkdesk Digital Lending also leverages best-in-class CX tools such as proactive borrower notifications, conversational AI-powered borrower self-service, and optimal out-of-the-box integrations to create a centralized hub of information for contact center agents. Furthermore, through Talkdesk AI TrainerTM , agents’ insights can now be utilized to optimize AI models and make the lending cycle easier.
The Talkdesk Digital Lending solution helps lenders to accelerate loan cycles and elevate the borrower CX by minimizing friction and putting borrowers at the forefront of every loan. The solution can handle high call volumes and spikes in demand, which many organizations have struggled with during the COVID-19 pandemic.
“Loan volumes have increased exponentially since 2019, during an historically low interest rate environment,” said Cory Haynes , vice president of financial services and insurance strategy, Talkdesk. “However, the loan application and navigation process has long been an area of frustration for many borrowers, who are looking for a faster, frictionless overall experience and greater transparency. By leveraging the Talkdesk Digital Lending solution, lenders can provide faster, more cost-efficient self-service that utilizes AI to learn and improve the overall client experience and potentially lower origination and servicing costs. Applying for a loan can be an incredibly emotional experience for individuals and businesses alike. Talkdesk Digital Lending raises the bar for the digital and human experience, while earning positive feedback from borrowers and improving lenders' bottom line."
On April 28, 2021, at LendIt Fintech USA 2021, Haynes will host a virtual fireside chat, ‘ Streamline the Borrower Experience with Talkdesk.’ He will be joined by Emma Reilly, senior vice president, head of enterprise program management, LendingClub . They will discuss how to accelerate the loan origination process, as well as delivering a seamless and transparent collections process. Find more details on LendIt Fintech USA 2021 .
The Talkdesk Digital Lending solution represents an expansion of the Talkdesk lending offering, which now helps lenders of any size in administering any type of loan. In January, Talkdesk launched the Talkdesk Small Business Lending solution , enabling lenders to streamline the administration of loans via the U.S. government’s Paycheck Protection Program, in order to support small business borrowers. Upside Financial leverages Talkdesk for their PPP support services at Upside Financial and their business travel services at Upside Business Travel, primarily through voice, making the process smoother for both agents and customers.
Additional Resources:
- Today, Talkdesk also unveiled a new logo and tagline – Experience. A better way. Read the press release detailing how Talkdesk enters its next decade fueled by innovation, expanded international presence and new brand.
- Also today, Talkdesk unveiled Talkdesk Workplace - a customizable interface designed to enable a better way to deliver superior customer experiences in contact centers. Read the press release introducing Talkdesk Workspace.
- See Talkdesk as a Leader by Gartner in the 2020 Magic Quadrant for Contact Center as a Service (CCaaS) and other recent awards and recognition .
- Hear directly from customers why they selected Talkdesk CX Cloud and the difference it has made in their contact centers.
- Talkdesk recently announced $143 million in Series C funding , increasing the company’s valuation to more than $3 billion.
Social Networks:
- Web: https://www.talkdesk.com
- Blog: https://www.talkdesk.com/blog/
- Twitter: https://twitter.com/Talkdesk
- LinkedIn: https://www.linkedin.com/company/talkdesk/
- Facebook: https://www.facebook.com/Talkdesk/
- Instagram: https://www.instagram.com/Talkdesk/
About Talkdesk
Talkdesk® is a global customer experience leader for customer-obsessed companies. Our contact center solution provides a better way for businesses and customers to engage with one another. Our speed of innovation and global footprint reflect our commitment to ensure businesses everywhere can deliver better customer experiences through any channel, resulting in higher customer satisfaction, cost savings and profitability. Talkdesk CX CloudTM is an end-to-end customer experience solution that combines enterprise scale with consumer simplicity. Over 1,800 innovative companies around the world, including IBM, Acxiom, Trivago, and Fujitsu partner with Talkdesk to deliver a better way to great customer experience. Learn more and request a demo at www.talkdesk.com .
Talkdesk is a registered trademark of Talkdesk, Inc. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210427005876/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
